Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use
-
AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine
-
Nirsevimab reduced respiratory syncytial virus infections and hospitalisations in preterm infants in Phase IIb trial
-
Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer
-
H1 2020 results
-
Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease
-
Calquence recommended for approval in the EU by CHMP for chronic lymphocytic leukaemia
-
Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer
-
AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise new antibody drug conjugate
-
Breztri Aerosphere approved in the US for the maintenance treatment of COPD
Latest articles and press releases
All of our latest press releases and articles are available to explore